Abstract:BACKGROUND:Cancer is increasingly recognized as a cellular system phenomenon that is attributed to the accumulation of genetic or epigenetic alterations leading to the perturbation of the molecular network architecture. Elucidation of network properties that can characterize tumor initiation and progression, or pinpoint the molecular targets related to the drug sensitivity or resistance, is therefore of critical importance for providing systems-level insights into tumorigenesis and clinical outcome in the molecularly targeted cancer therapy.RESULTS:In this study, we developed a network-based framework to quantitatively examine cellular network heterogeneity and modularity in cancer. Specifically, we constructed gene co-expressed protein interaction networks derived from large-scale RNA-Seq data across 8 cancer types generated in The Cancer Genome Atlas (TCGA) project. We performed gene network entropy and balanced versus unbalanced motif analysis to investigate cellular network heterogeneity and modularity in tumor versus normal tissues, different stages of progression, and drug resistant versus sensitive cancer cell lines. We found that tumorigenesis could be characterized by a significant increase of gene network entropy in all of the 8 cancer types. The ratio of the balanced motifs in normal tissues is higher than that of tumors, while the ratio of unbalanced motifs in tumors is higher than that of normal tissues in all of the 8 cancer types. Furthermore, we showed that network entropy could be used to characterize tumor progression and anticancer drug responses. For example, we found that kinase inhibitor resistant cancer cell lines had higher entropy compared to that of sensitive cell lines using the integrative analysis of microarray gene expression and drug pharmacological data collected from the Genomics of Drug Sensitivity in Cancer database. In addition, we provided potential network-level evidence that smoking might increase cancer cellular network heterogeneity and further contribute to tyrosine kinase inhibitor (e.g., gefitinib) resistance.CONCLUSION:In summary, we demonstrated that network properties such as network entropy and unbalanced motifs associated with tumor initiation, progression, and anticancer drug responses, suggesting new potential network-based prognostic and predictive measure in cancer.

Identifying Lymph Node Metastasis-Related Factors in Breast Cancer Using Differential Modular and Mutational Structural Analysis

Integrated cross-species transcriptional network analysis of metastatic susceptibility

An Integrated Cross-Species Transcriptional Network Analysis Of Metastatic Susceptibility

Identification of significantly mutated subnetworks in the breast cancer genome

Identification of breast cancer risk modules via an integrated strategy

Peeling Off the Hidden Genetic Heterogeneities of Cancers Based on Disease-Relevant Functional Modules

Bioinformatics Analysis for the Identification of Key Genes and Long Non-Coding RNAs Related to Bone Metastasis in Breast Cancer.

Extracting Stage-Specific and Dynamic Modules Through Analyzing Multiple Networks Associated with Cancer Progression

Identification of cancer prognosis-associated functional modules using differential co-expression networks.

Integrated Multi-Omics Analysis Model to Identify Biomarkers Associated With Prognosis of Breast Cancer

Investigating Cellular Network Heterogeneity and Modularity in Cancer: a Network Entropy and Unbalanced Motif Approach.

Discovery of Significant Pathways in Breast Cancer Metastasis Via Module Extraction and Comparison

A signal-based method for finding driver modules of breast cancer metastasis to the lung

Network-based Co-Expression Analysis for Exploring the Potential Diagnostic Biomarkers of Metastatic Melanoma

Integrative analysis of dysfunctional modules driven by genomic alterations at system level across 11 cancer types.

A Functional Network Construction Method to Interpret the Pathological Process of Colorectal Cancer

Identification of Cancer Driver Modules by Combining Network Functional and Topology Information.

Exploring the molecular mechanism associated with breast cancer bone metastasis using bioinformatic analysis and microarray genetic interaction network

Cancer Core Modules Identification Through Genomic and Transcriptomic Changes Correlation Detection at Network Level.

Identifying Disease Genes and Module Biomarkers by Differential Interactions

Structural deep clustering network for stratification of breast cancer patients through integration of somatic mutation profiles